C12N 2770/32034
Use of virus or viral component as vaccine
Official title: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
C12N2770/32034 (Use of virus or viral component as vaccine) appears on 37 US grants and 46 published applications in this corpus.
Search patents in C12N- Granted patents
- 37
- Published applications
- 46
- Assignees
- 43
- Inventors
- 149
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 2 |
| 2016 | 1 | 1 |
| 2017 | 0 | 1 |
| 2018 | 4 | 8 |
| 2019 | 6 | 3 |
| 2020 | 3 | 4 |
| 2021 | 3 | 4 |
| 2022 | 2 | 6 |
| 2023 | 4 | 3 |
| 2024 | 3 | 2 |
| 2025 | 3 | 5 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Senecavirus A virus strains and immunogenic compositions therefrom6 Jan 2026US 12,514,917 B2South Dakota Board of Regents
- Pharmaceutical composition containing stabilized nucleic acid adjuvant11 Nov 2025US 12,465,644 B2Sml Biopharm Co., Ltd.
- Cancer immunotherapy using virus particles8 Jul 2025US 12,350,326 B2Case Western Reserve University
- Foot-and-mouth disease vaccine29 Apr 2025US 12,285,478 B2The United States of America as represented by the Secretary of Agriculture
- Broad-spectrum polypeptide against enterovirus and application thereof4 Jun 2024US 11,999,806 B2Fudan University
- Foot-and-mouth disease vaccine25 Jun 2026US 2026/0174842 A1The United States of America as represented by the Secretary of Agriculture
- Lipid nanoparticle composition comprising gallic acid derivative lipid and use thereof3 Jul 2025US 2025/0213680 A1Korea Institute of Science and Technology
- Viral Vaccines27 Mar 2025US 2025/0101066 A1
- T-cell epitope polypeptide of senecavirus a and uses thereof13 Mar 2025US 2025/0084132 A1Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Compositions and methods for protein expression with rna16 Jan 2025US 2025/0018024 A1Excepgen Inc.
Most cited
By later US patents
- Method for treating viral diseases with attenuated virus13US 5,124,148 AUnited Cancer Research Institute · 1992
- Method for treating viral diseases with attenuated virus10US 5,215,745 AUnited Cancer Research Institute · 1993
- Method for producing non-infectious recombinant picornavirus particles8US 6,440,718 B1november Aktiengesellschaft Gesellschaft fur Molekulare Medizin · 2002
- Avian polynucleotide formula5US 6,221,362 B1Merial Limited · 2001
- Vaccine against avian encephalomyelitis4US 5,208,023 AMinister of Agriculture, Fisheries & Food in Majesty's Government of Great Britain · 1993